Predictive factors for therapeutic response to radioactive iodine therapy in pulmonary metastases from differentiated thyroid carcinoma
Ken Watanabe, Takao Igarashi, Yuki Hayakawa, Kimiyuki Uchihara, Takashi Kazama, Hiroya Ojiri · 2026
Read Predictive factors for therapeutic response to radioactive iodine therapy in pulmonary metastases from differentiated thyroid carcinoma by Ken Watanabe, Takao Igarashi, Yuki Hayakawa, Kimiyuki Uchihara, Takashi Kazama, Hiroya Ojiri (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13400580.txt.
Description
Ken Watanabe and colleagues analyze, in 2026, which patients with thyroid cancer spread to the lungs respond to radioactive iodine therapy. The treatment is a mainstay for differentiated thyroid cancer, yet results vary widely once lung spread occurs. Predicting response could spare futile treatment.
The team reviewed 186 patients treated between 2010 and 2024, grading response by scans, imaging of iodine uptake and a blood marker. Overall disease control, counting complete, partial and stable outcomes, was under a quarter of cases. Patients younger than 55 and those whose lung spread was found at the time of thyroid surgery fared better. A lung uptake score also tracked outcome strongly, while the starting dose made no clear difference.
Catalog record
| CREATOR | Ken Watanabe, Takao Igarashi, Yuki Hayakawa, Kimiyuki Uchihara, Takashi Kazama, Hiroya Ojiri |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 33709 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |